Alerts will be sent to your verified email
Verify EmailNone
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Accretion Nutraveda is engaged in manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, and Oral Powders, etc. It is a healthcare focused company specialising in contract manufacturing, serving domestic as well as export markets in various countries. It offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science.
Accretion Nutraveda major competitors are Walpar Nutritions, Influx Healthtech.
Market Cap of Accretion Nutraveda is ₹0 Crs.
While the median market cap of its peers are ₹268 Crs.
Accretion Nutraveda seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|